Psyence Biomedical (PBMWW) Competitors $0.02 0.00 (0.00%) As of 10:42 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends PBMWW vs. ATNFW, LBPSW, AARD, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aardvark Therapeutics (AARD), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. 180 Life Sciences 4D pharma Aardvark Therapeutics Aesther Healthcare Acquisition Ainos Alvotech Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Psyence Biomedical (NASDAQ:PBMWW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends. Does the media prefer ATNFW or PBMWW? In the previous week, Psyence Biomedical had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 2 mentions for Psyence Biomedical and 1 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat Psyence Biomedical's score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive Psyence Biomedical Neutral Which has higher earnings & valuation, ATNFW or PBMWW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/APsyence BiomedicalN/AN/AN/AN/AN/A Is ATNFW or PBMWW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Psyence Biomedical N/A N/A N/A Does the MarketBeat Community favor ATNFW or PBMWW? 180 Life Sciences and Psyence Biomedical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/APsyence BiomedicalN/AN/A Summary180 Life Sciences and Psyence Biomedical tied by winning 1 of the 2 factors compared between the two stocks. Remove Ads Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBMWW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBMWW vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical Preparations IndustryManufacturing SectorNASDAQ ExchangeMarket CapN/A$6.92B$2.18B$8.05BDividend YieldN/A2.71%2.65%4.04%P/E RatioN/A6.1524.7218.95Price / SalesN/A224.1181.04116.93Price / CashN/A65.67N/A34.62Price / BookN/A6.581.904.22Net IncomeN/A$139.77M-$452.02M$246.59M7 Day PerformanceN/A-1.56%-2.29%-3.12%1 Month PerformanceN/A-6.78%-3.59%-9.01%1 Year PerformanceN/A-7.22%1.61%0.99% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMWWPsyence BiomedicalN/A$0.02flatN/A-80.4%$0.00N/A0.00N/AShort Interest ↓ATNFW180 Life SciencesN/A$0.01+3.0%N/A+21.4%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAARDAardvark TherapeuticsN/A$12.00-5.7%N/AN/A$0.00N/A0.0018Analyst ForecastAnalyst RevisionNews CoveragePositive NewsAEHAWAesther Healthcare AcquisitionN/A$0.03+17.0%N/A-85.4%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.08-12.0%N/A+73.4%$0.00$40,633.000.0040Positive NewsGap UpALVOWAlvotechN/A$2.05-6.8%N/A-64.5%$0.00$391.87M0.004Gap DownACABWAtlantic Coastal Acquisition Corp. IIN/A$0.03-2.9%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.08+36.4%N/A+45.0%$0.00$35.36M0.0070Positive NewsGap UpBTMDWbioteN/A$0.08-22.7%N/AN/A$0.00$193.06M0.00N/ABCTXWBriaCell TherapeuticsN/A$0.10-5.0%N/A-93.6%$0.00N/A0.008Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies 180 Life Sciences Alternatives 4D pharma Alternatives Aardvark Therapeutics Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Atlantic Coastal Acquisition Corp. II Alternatives Biofrontera Alternatives biote Alternatives BriaCell Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PBMWW) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredFormer CIA to Trump – Will you Shut down this secret lab?Deep in the sands of New Mexico lies a government lab so secret it makes Area 51 look like a tourist spot… ...Paradigm Press | SponsoredDeFi Coin on Verge of Breakout!We’re Opening the Ultimate Crypto Vault… Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Victory Could Spark Major Gains for Gold – Don’t Miss Out This "Patriot's Tax Shield" lets you defend your wealth with real, solid gold. Our exclusive, free wealth pr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
